Used primarily as a key intermediate in pharmaceutical synthesis, especially in Suzuki-Miyaura cross-coupling reactions to construct biaryl or heteroaryl frameworks. Its boronate ester group enables efficient carbon-carbon bond formation under mild conditions, making it valuable in the development of active pharmaceutical ingredients (APIs). The pyrazole core is common in bioactive molecules, so this compound supports the creation of potential drug candidates targeting inflammation, cancer, and central nervous system disorders. It is particularly useful in medicinal chemistry for rapid library synthesis in drug discovery programs.